Efficacy and Safety Study of ABT-436 in Major Depressive Disorder

Study Identifier
M11-733
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

Study Details

Medical Condition
  • Depression
  • Study Drug
  • ABT-436
  • Escitalopram
  • Placebo
  • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18 - 65 Years

    Protocol Summary

    The purpose is to study the efficacy and safety of ABT-436 in Major Depressive Disorder.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 85593
    Little Rock, Arkansas, United States, 72211
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 87228
    Garden Grove, California, United States, 92845
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 87214
    National City, California, United States, 91950
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 87220
    Oakland, California, United States, 94612
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 87215
    Bradenton, Florida, United States, 34201
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 87225
    South Miami, Florida, United States, 33143
    Status
    Not applicable
    Showing {first} - {last} of {total} Results